Lindsey Adair MacFarlane, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 14 | 2023 | 1234 | 3.170 |
Why?
|
| Synovitis | 4 | 2023 | 215 | 2.030 |
Why?
|
| Knee Injuries | 4 | 2023 | 489 | 1.340 |
Why?
|
| Knee Joint | 6 | 2023 | 1663 | 1.330 |
Why?
|
| Arthralgia | 2 | 2018 | 461 | 0.860 |
Why?
|
| Dermatomyositis | 2 | 2016 | 256 | 0.850 |
Why?
|
| Hyperuricemia | 2 | 2016 | 225 | 0.810 |
Why?
|
| Physical Therapy Modalities | 4 | 2023 | 536 | 0.780 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2021 | 1387 | 0.750 |
Why?
|
| Edema | 3 | 2019 | 769 | 0.680 |
Why?
|
| Vitamin D | 3 | 2021 | 3291 | 0.620 |
Why?
|
| Arthroscopy | 3 | 2022 | 960 | 0.620 |
Why?
|
| Gout | 2 | 2016 | 620 | 0.610 |
Why?
|
| Arthroplasty, Replacement | 1 | 2019 | 310 | 0.520 |
Why?
|
| Angioedema | 1 | 2016 | 192 | 0.470 |
Why?
|
| Antirheumatic Agents | 3 | 2023 | 1374 | 0.450 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2023 | 3763 | 0.440 |
Why?
|
| Diabetes Complications | 1 | 2019 | 1341 | 0.410 |
Why?
|
| Vitamins | 1 | 2020 | 1634 | 0.400 |
Why?
|
| Perioperative Care | 1 | 2019 | 1037 | 0.390 |
Why?
|
| Dietary Supplements | 3 | 2021 | 3392 | 0.380 |
Why?
|
| Osteoarthritis | 1 | 2019 | 1055 | 0.380 |
Why?
|
| Cartilage, Articular | 1 | 2018 | 1091 | 0.380 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 4925 | 0.370 |
Why?
|
| Hyperglycemia | 1 | 2019 | 1380 | 0.360 |
Why?
|
| Injections, Intra-Articular | 2 | 2022 | 279 | 0.360 |
Why?
|
| Uric Acid | 1 | 2014 | 806 | 0.310 |
Why?
|
| Menisci, Tibial | 2 | 2022 | 269 | 0.290 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2018 | 1370 | 0.280 |
Why?
|
| Protein Kinases | 1 | 2014 | 1612 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2023 | 36290 | 0.250 |
Why?
|
| Pain | 6 | 2023 | 5066 | 0.250 |
Why?
|
| Blood Glucose | 1 | 2019 | 6381 | 0.240 |
Why?
|
| Synovial Fluid | 2 | 2023 | 395 | 0.230 |
Why?
|
| Physicians | 1 | 2022 | 4591 | 0.220 |
Why?
|
| Hypoglycemic Agents | 2 | 2014 | 3150 | 0.220 |
Why?
|
| Middle Aged | 21 | 2023 | 220352 | 0.200 |
Why?
|
| Aged | 17 | 2023 | 169152 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 3388 | 0.200 |
Why?
|
| Databases, Factual | 1 | 2016 | 8035 | 0.180 |
Why?
|
| Arthritis, Psoriatic | 1 | 2023 | 219 | 0.180 |
Why?
|
| CD40 Ligand | 3 | 2007 | 521 | 0.180 |
Why?
|
| Deglutition Disorders | 2 | 2016 | 626 | 0.170 |
Why?
|
| Insulin | 1 | 2014 | 6597 | 0.170 |
Why?
|
| Strabismus | 1 | 2024 | 317 | 0.170 |
Why?
|
| Male | 24 | 2024 | 359744 | 0.170 |
Why?
|
| Atherosclerosis | 7 | 2010 | 3517 | 0.170 |
Why?
|
| Glucocorticoids | 3 | 2024 | 2145 | 0.170 |
Why?
|
| Humans | 38 | 2024 | 760621 | 0.160 |
Why?
|
| TNF Receptor-Associated Factor 1 | 2 | 2010 | 50 | 0.160 |
Why?
|
| Bone Diseases | 1 | 2022 | 419 | 0.160 |
Why?
|
| Leukocyte Count | 1 | 2023 | 1600 | 0.160 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2019 | 227 | 0.150 |
Why?
|
| Patient Preference | 2 | 2022 | 922 | 0.150 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2017 | 53 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5643 | 0.140 |
Why?
|
| Pain Measurement | 2 | 2018 | 3528 | 0.140 |
Why?
|
| Inflammation | 5 | 2023 | 10756 | 0.140 |
Why?
|
| Ontario | 1 | 2018 | 404 | 0.140 |
Why?
|
| Female | 20 | 2023 | 391270 | 0.140 |
Why?
|
| Diet | 1 | 2014 | 8010 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5889 | 0.130 |
Why?
|
| Algorithms | 1 | 2016 | 13981 | 0.130 |
Why?
|
| Qualitative Research | 2 | 2022 | 2963 | 0.120 |
Why?
|
| Methotrexate | 2 | 2023 | 1719 | 0.120 |
Why?
|
| Biopsy | 2 | 2016 | 6771 | 0.110 |
Why?
|
| Biological Products | 1 | 2023 | 916 | 0.110 |
Why?
|
| Muscle Weakness | 1 | 2016 | 413 | 0.110 |
Why?
|
| Janus Kinases | 1 | 2014 | 250 | 0.100 |
Why?
|
| Thyrotropin | 1 | 2016 | 832 | 0.100 |
Why?
|
| Obesity | 1 | 2014 | 12922 | 0.100 |
Why?
|
| Recurrence | 1 | 2024 | 8482 | 0.100 |
Why?
|
| Neck | 1 | 2016 | 731 | 0.100 |
Why?
|
| Exanthema | 1 | 2016 | 504 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12965 | 0.090 |
Why?
|
| Eye Diseases | 1 | 2016 | 651 | 0.090 |
Why?
|
| Mast Cells | 2 | 2007 | 1390 | 0.090 |
Why?
|
| Receptors, CCR1 | 1 | 2009 | 31 | 0.090 |
Why?
|
| Medicare | 2 | 2019 | 6786 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4550 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2020 | 12427 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2010 | 1223 | 0.080 |
Why?
|
| Cystatin C | 1 | 2010 | 270 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2010 | 686 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 58995 | 0.080 |
Why?
|
| Drug Design | 1 | 2014 | 1061 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2023 | 65017 | 0.080 |
Why?
|
| Pancreatic Elastase | 1 | 2007 | 128 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 5 | 1 | 2007 | 6 | 0.070 |
Why?
|
| Pyrroles | 1 | 2014 | 1137 | 0.070 |
Why?
|
| Tunica Intima | 1 | 2009 | 459 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2007 | 39 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 57 | 0.070 |
Why?
|
| Angiotensin II | 1 | 2010 | 849 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2022 | 3986 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2007 | 62 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 25942 | 0.070 |
Why?
|
| Linear Models | 1 | 2016 | 5877 | 0.070 |
Why?
|
| Aortic Diseases | 2 | 2009 | 736 | 0.070 |
Why?
|
| Macrophage-1 Antigen | 1 | 2007 | 286 | 0.070 |
Why?
|
| Vasculitis | 1 | 2010 | 523 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2007 | 251 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2754 | 0.060 |
Why?
|
| Piperidines | 1 | 2014 | 1650 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 10344 | 0.060 |
Why?
|
| Aorta | 2 | 2009 | 2039 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 5423 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 18416 | 0.060 |
Why?
|
| Lichen Planus | 1 | 2024 | 71 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12159 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 13502 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4166 | 0.050 |
Why?
|
| Risk Factors | 4 | 2023 | 74359 | 0.050 |
Why?
|
| Diplopia | 1 | 2024 | 215 | 0.050 |
Why?
|
| Sex Factors | 2 | 2014 | 10547 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2803 | 0.050 |
Why?
|
| Interleukin-6 | 4 | 2019 | 3215 | 0.050 |
Why?
|
| United States | 3 | 2019 | 72461 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2014 | 3016 | 0.050 |
Why?
|
| Macrophages | 4 | 2010 | 5745 | 0.050 |
Why?
|
| Knee | 1 | 2023 | 276 | 0.050 |
Why?
|
| Receptors, LDL | 3 | 2010 | 488 | 0.050 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2024 | 353 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9185 | 0.040 |
Why?
|
| Oculomotor Muscles | 1 | 2024 | 407 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2010 | 3539 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15289 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15840 | 0.040 |
Why?
|
| Adult | 5 | 2022 | 219994 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13262 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2016 | 4775 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 422 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 1881 | 0.040 |
Why?
|
| Arteries | 1 | 2023 | 1126 | 0.040 |
Why?
|
| Metformin | 1 | 2005 | 912 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20080 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2005 | 1155 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 346 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 41335 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2005 | 2488 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2693 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2023 | 80372 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 1765 | 0.030 |
Why?
|
| Focus Groups | 1 | 2022 | 1378 | 0.030 |
Why?
|
| Mice, Knockout | 5 | 2010 | 14372 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1796 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 8594 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 4357 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 17790 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13630 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 1753 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2023 | 1588 | 0.030 |
Why?
|
| Animals | 9 | 2014 | 167963 | 0.030 |
Why?
|
| Saphenous Vein | 2 | 2007 | 537 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22072 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2023 | 6498 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 5 | 2010 | 22023 | 0.030 |
Why?
|
| Cytokines | 1 | 2007 | 7343 | 0.030 |
Why?
|
| Mice | 8 | 2010 | 81208 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23376 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2009 | 215 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2005 | 1485 | 0.020 |
Why?
|
| Decision Making | 1 | 2022 | 3925 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 3839 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 6659 | 0.020 |
Why?
|
| Transplants | 1 | 2009 | 206 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2007 | 93 | 0.020 |
Why?
|
| Foam Cells | 1 | 2007 | 68 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2010 | 655 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2007 | 223 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2009 | 1155 | 0.020 |
Why?
|
| Texas | 1 | 2007 | 401 | 0.020 |
Why?
|
| Elastin | 1 | 2007 | 301 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2007 | 818 | 0.020 |
Why?
|
| Rheology | 1 | 2007 | 348 | 0.020 |
Why?
|
| Chemokines | 1 | 2010 | 962 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 751 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 815 | 0.020 |
Why?
|
| Peritonitis | 1 | 2007 | 369 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1436 | 0.010 |
Why?
|
| CHO Cells | 1 | 2007 | 1389 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2007 | 663 | 0.010 |
Why?
|
| Endothelium, Vascular | 2 | 2007 | 4433 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2010 | 10446 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2022 | 22053 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 1602 | 0.010 |
Why?
|
| Peroxidase | 1 | 2007 | 605 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 727 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3094 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2427 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14495 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2005 | 698 | 0.010 |
Why?
|
| Actins | 1 | 2010 | 2049 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2414 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2010 | 18957 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 3218 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2005 | 625 | 0.010 |
Why?
|
| Leukocytes | 1 | 2010 | 2026 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2005 | 1249 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 4312 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2007 | 1097 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2005 | 822 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 5039 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3157 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39261 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 5206 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40165 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3442 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 2575 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6068 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2448 | 0.010 |
Why?
|
| Acute Coronary Syndrome | 1 | 2010 | 2365 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2864 | 0.010 |
Why?
|
| Lipids | 1 | 2007 | 3336 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 5797 | 0.010 |
Why?
|
| Life Style | 1 | 2007 | 3896 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 9530 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 7588 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9501 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 4351 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11481 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9467 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 12293 | 0.000 |
Why?
|